Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer.

Bloem LT, De Abreu Lourenço R, Chin M, Ly B, Haas M.

Oncol Ther. 2016;4(1):103-116. doi: 10.1007/s40487-016-0020-4. Epub 2016 May 11.

2.

Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer.

Tominaga T, Nonaka T, Sumida Y, Hidaka S, Sawai T, Nagayasu T.

World J Surg Oncol. 2016 Jul 28;14(1):197. doi: 10.1186/s12957-016-0959-5.

3.

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience.

Ocvirk J, Moltara ME, Mesti T, Boc M, Rebersek M, Volk N, Benedik J, Hlebanja Z.

Radiol Oncol. 2016 Apr 23;50(2):226-31. doi: 10.1515/raon-2015-0030. eCollection 2016 Jun 1.

4.
5.

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.

Hsieh MC, Thompson T, Wu XC, Styles T, O'Flarity MB, Morris CR, Chen VW.

Cancer Med. 2016 May;5(5):871-80. doi: 10.1002/cam4.632. Epub 2016 Jan 15.

6.

Characteristics affecting survival after locally advanced colorectal cancer in Quebec.

Perron L, Daigle JM, Vandal N, Guertin MH, Brisson J.

Curr Oncol. 2015 Dec;22(6):e485-92. doi: 10.3747/co.22.2692.

7.

Factors Associated With Unplanned Hospitalizations Among Patients With Nonmetastatic Colorectal Cancers Intended for Treatment in the Ambulatory Setting.

Fessele KL, Hayat MJ, Mayer DK, Atkins RL.

Nurs Res. 2016 Jan-Feb;65(1):24-34. doi: 10.1097/NNR.0000000000000134.

8.

Patterns of Colorectal Cancer Care in the United States: 1990-2010.

Murphy CC, Harlan LC, Lund JL, Lynch CF, Geiger AM.

J Natl Cancer Inst. 2015 Jul 23;107(10). pii: djv198. doi: 10.1093/jnci/djv198. Print 2015 Oct.

9.

Chemotherapy for colorectal cancer in the elderly.

Kim JH.

World J Gastroenterol. 2015 May 7;21(17):5158-66. doi: 10.3748/wjg.v21.i17.5158. Review.

10.

Colorectal cancer screening and surveillance in the elderly: updates and controversies.

Day LW, Velayos F.

Gut Liver. 2015 Mar;9(2):143-51. doi: 10.5009/gnl14302. Review.

11.

Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings.

Tashiro J, Yamaguchi S, Ishii T, Suzuki A, Kondo H, Morita Y, Hara K, Koyama I.

World J Surg Oncol. 2014 May 10;12:145. doi: 10.1186/1477-7819-12-145.

12.

Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer.

Fitzgerald TL, Zervos E, Wong JH.

J Cancer Epidemiol. 2013;2013:408460. doi: 10.1155/2013/408460. Epub 2013 Oct 2.

13.

Patterns of colorectal cancer care in the United States and Canada: a systematic review.

Butler EN, Chawla N, Lund J, Harlan LC, Warren JL, Yabroff KR.

J Natl Cancer Inst Monogr. 2013;2013(46):13-35. doi: 10.1093/jncimonographs/lgt007. Review.

14.
15.

Uptake of oxaliplatin and bevacizumab for treatment of node-positive and metastatic colon cancer.

Neugut AI, Becker DJ, Insel BJ, Hershman DL.

J Oncol Pract. 2012 May;8(3):156-63. doi: 10.1200/JOP.2011.000371. Epub 2012 Jan 11.

16.

Differences in the therapeutic approach to colorectal cancer in young and elderly patients.

Serra-Rexach JA, Jimenez AB, García-Alhambra MA, Pla R, Vidán M, Rodríguez P, Ortiz J, García-Alfonso P, Martín M.

Oncologist. 2012;17(10):1277-85. doi: 10.1634/theoncologist.2012-0060. Epub 2012 Aug 23.

17.

Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

Sanoff HK, Carpenter WR, Stürmer T, Goldberg RM, Martin CF, Fine JP, McCleary NJ, Meyerhardt JA, Niland J, Kahn KL, Schymura MJ, Schrag D.

J Clin Oncol. 2012 Jul 20;30(21):2624-34. doi: 10.1200/JCO.2011.41.1140. Epub 2012 Jun 4.

18.

Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.

Sanoff HK, Carpenter WR, Martin CF, Sargent DJ, Meyerhardt JA, Stürmer T, Fine JP, Weeks J, Niland J, Kahn KL, Schymura MJ, Schrag D.

J Natl Cancer Inst. 2012 Feb 8;104(3):211-27. doi: 10.1093/jnci/djr524. Epub 2012 Jan 20.

19.

Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects.

Bastos DA, Ribeiro SC, de Freitas D, Hoff PM.

Ther Adv Med Oncol. 2010 Jul;2(4):261-72. doi: 10.1177/1758834010367905.

20.

Systemic therapy for elderly patients with gastrointestinal cancer.

Hubbard JM, Grothey A, Sargent DJ.

Clin Med Insights Oncol. 2011;5:89-99. doi: 10.4137/CMO.S6983. Epub 2011 Apr 25.

Supplemental Content

Support Center